Search

Your search keyword '"Aberg A"' showing total 5,205 results

Search Constraints

Start Over You searched for: Author "Aberg A" Remove constraint Author: "Aberg A"
5,205 results on '"Aberg A"'

Search Results

1. Formation of transfermium elements in reactions with $^{208}$Pb

2. Runtime-coherence trade-offs for hybrid SAT-solvers

3. Demagnetization dynamics after noncollinear dual optical excitation

4. Optically Induced Ferromagnetic Order in a Ferrimagnet

5. Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE Cohort

6. Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency Virus

7. PRC2-AgeIndex as a universal biomarker of aging and rejuvenation

9. Spectral-partitioned Kohn-Sham density functional theory

15. Did the Pandemic Increase Social Media–Induced Appearance Pressures?

16. Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV

17. Impact of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV

18. Coronary Artery Plaque Composition and Severity Relate to the Inflammasome in People With Treated Human Immunodeficiency Virus

19. Pro-inflammatory and pro-resolving lipid mediators of inflammation in HIV: effect of aspirin intervention

20. Extending the analogy between intracellular motion in mammalian cells and glassy dynamics

21. Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV)

22. Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States

23. Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy

24. Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy

25. Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXID

28. Association of Cardiac Troponin T With Coronary Atherosclerosis in Asymptomatic Primary Prevention People With HIV

31. Suboptimal and trait-like reinforcement learning strategies correlate with midbrain encoding of prediction errors

32. Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study

34. The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus

38. Thrombosis risk in single- and double-heterozygous carriers of factor V Leiden and prothrombin G20210A in FinnGen and the UK Biobank

39. Coronary Plaque in People With HIV vs Non-HIV Asymptomatic Community and Symptomatic Higher-Risk Populations

42. High-Resolution Genotyping of Formalin-Fixed Tissue Accurately Estimates Polygenic Risk Scores in Human Diseases

45. COVID-19 Vaccination Rates in a Global HIV Cohort

46. Test Automation with Grad-CAM Heatmaps -- A Future Pipe Segment in MLOps for Vision AI?

47. Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial

48. Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus

49. Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial

Catalog

Books, media, physical & digital resources